Health ❯ Medicine ❯ Pharmaceuticals

Drug Trials

Relyvrio Clinical Trials RAP-219 Alzheimer's Disease

Rapport Seizure Drug Posts Strong Phase 2 Signal as Company Plans Phase 3

Analysts cheered unusually large reductions from a small open-label study, which now require confirmation in randomized trials.